Ebrahim Versi

Insider Reports History

Location
San Diego, CA
Signature
/s/ David J. Marguglio, as Attorney-in-Fact for Ebrahim Versi
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ebrahim Versi:

Company Role Class Num Shares Value Price $ Report Date Ownership
DMK PHARMACEUTICALS Corp CEO, Director Common Stock 906,394 $547,099 $0.6036 15 Sep 2023 By Versi Group LLC
DMK PHARMACEUTICALS Corp CEO, Director Common Stock 8,745 $5,278 $0.6036 15 Sep 2023 Direct
DMK PHARMACEUTICALS Corp CEO, Director Series E Convertible Preferred Stock 1,212 15 Sep 2023 By Versi Group LLC

Insider Reports Filed by Ebrahim Versi

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ADMP DMK PHARMACEUTICALS Corp 15 Sep 2023 2 $0 4 CEO, Director 19 Sep 2023, 17:17
ADMP Adamis Pharmaceuticals Corp 25 May 2023 8 $0 4 CEO, Director 30 May 2023, 18:16
ADMP Adamis Pharmaceuticals Corp 25 May 2023 0 $0 3 CEO, Director 30 May 2023, 18:11